A-shares closed · 港股交易中 Quotes 行情 · 28 Sep 11:39 CST
28 Sep 2026 · 11:39 CST Terminal Access 终端入口 →
688013.SH上海证券交易所 · 科创板 STAR

Touchstone 天臣医疗

Medical Devices 医疗器械
¥24.52−¥0.70 · −2.78%Delayed 行情延迟 · 28 Sep 2026 · 11:38 CST · CNY
Open 开盘
¥25.35
High 最高
¥26.33
Low 最低
¥24.40
Prev Close 昨收
¥25.22
Volume 成交量
117.6万股
Turnover 成交额
¥2,943.3万
Mkt Cap 总市值
¥20亿
P/E 市盈率
39.2×
Recent Activity 近期动态All Filings 全部公告 →

11 significant filings since 31 May 2026: 3 on regulatory inquiry, 5 on buyback and 2 on dividend, and 1 other kind. The latest, on 3 Sep 2026: 天臣医疗关于以集中竞价交易方式回购公司股份的进展公告.
自 31 May 2026 起有 11 份重大公告:regulatory inquiry 3 份、buyback 5 份、dividend 2 份,另有 1 类。最新一份(3 Sep 2026):天臣医疗关于以集中竞价交易方式回购公司股份的进展公告。

Price History 价格走势

1,453 trading days 个交易日 · High 最高 ¥64.67 · Low 最低 ¥11.21
20.0030.0040.0050.0060.00
Volume 成交量
1,356.5万
20202022202320252026

Against Its Own History 与自身历史比较

39.2×
Median 中值 38.2× · Range 区间 23.6× to 59.2× · 20 periods 期
4.02×
Median 中值 3.44× · Range 区间 2.01× to 8.17× · 20 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥24.67¥0.6339.2×¥6.104.05×
31 Mar 2026 一季报¥37.17¥1.0136.8×¥7.115.23×
31 Dec 2025 年报¥48.08¥1.0645.4×¥6.976.90×
30 Sep 2025 三季报¥60.36¥1.0259.2×¥7.398.17×
30 Jun 2025 中报¥29.23¥0.8932.8×¥7.084.13×
31 Mar 2025 一季报¥18.94¥0.6827.9×¥7.042.69×
31 Dec 2024 年报¥17.61¥0.6527.1×¥7.162.46×
30 Sep 2024 三季报¥18.16¥0.7225.2×¥7.052.58×
30 Jun 2024 中报¥14.84¥0.6323.6×¥7.392.01×
31 Mar 2024 一季报¥17.88¥0.6029.8×¥6.812.63×
31 Dec 2023 年报¥21.10¥0.6035.2×¥7.043.00×
30 Sep 2023 三季报¥22.72¥0.5541.3×¥6.803.34×
30 Jun 2023 中报¥23.71¥0.6337.6×¥6.633.58×
31 Mar 2023 一季报¥22.85¥0.5938.7×¥6.463.54×
31 Dec 2022 年报¥19.39¥0.5435.9×¥6.263.10×
30 Sep 2022 三季报¥19.36¥0.4741.2×¥6.263.09×
30 Jun 2022 中报¥19.62¥0.4543.6×¥6.363.09×
31 Mar 2022 一季报¥23.37¥0.4551.9×¥6.483.61×
31 Dec 2021 年报¥25.44¥0.5248.9×¥6.403.97×
30 Sep 2021 三季报¥24.94¥0.5644.5×¥6.244.00×

Consensus Forward EPS 机构预测每股收益

No broker forecasts for this company yet 暂无机构预测

Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA